2-Hydroxyethyl Mercapturic Acid

Every day, your body comes into contact with chemicals that quietly attach to your DNA and proteins. Ethylene oxide is a highly reactive alkylating agent classified as a known human carcinogen, showing up in cigarette smoke, in air near industrial facilities, and in hospitals where it sterilizes medical equipment. This urine test gives you a window into how much of that chemical class your body has had to neutralize in the past day or two.

HEMA (2-hydroxyethyl mercapturic acid) is the breakdown product your body excretes after defusing these reactive molecules. It is mostly used in research and biomonitoring, not in routine clinical practice, but it can confirm whether your environment or habits are loading your body with a known carcinogen, often when standard lab panels show nothing.

What HEMA Actually Reflects

HEMA is the urinary end product your body makes primarily when it neutralizes ethylene oxide and acrylonitrile, the two best-established sources. It is not specific to a single chemical: other reactive two-carbon compounds can in theory contribute through the same pathway, but ethylene oxide and acrylonitrile are the dominant sources in everyday exposure. These chemicals attach to DNA and proteins, which is why your liver wraps them in a protective tag called glutathione (your cells' main detoxifying molecule), processes them through cysteine, and sends them out in urine as a mercapturic acid.

Because HEMA is excreted quickly, the level you measure reflects what you have been exposed to in roughly the past few days, not your lifetime burden. That makes it a snapshot of recent exposure rather than a verdict on long-term risk.

Tobacco Smoke as the Dominant Source

If you smoke, this is almost certainly your largest source of ethylene oxide exposure. In a study of 7,416 adults in the NHANES survey, people who smoked 10 to 19 cigarettes per day had 36% higher urinary HEMA than those smoking 1 to 9, and people smoking more than 19 per day had 61% higher levels. The biomarker tracks closely with serum cotinine, a standard measure of nicotine exposure.

HEMA also responds fast when smokers quit. In adults who stopped smoking, urinary HEMA fell by roughly 81 to 91% within three days and stayed low through the 56-day observation period. This rapid drop is one reason researchers use HEMA to verify that someone has actually quit or switched products, rather than just claimed to.

Lung Cancer Risk in Smokers

In the Shanghai Cohort Study of Chinese men followed for nearly two decades, smokers with HEMA in the highest third of measurements had about twice the lung cancer risk of those in the lowest third (odds ratio 1.96, 95% CI 1.06 to 3.60), even after accounting for how many cigarettes they smoked and for how long.

That association vanished once researchers adjusted for urinary cotinine, the standard biomarker of nicotine intake. The plain reading: HEMA captures real biological damage from smoke, but it does not appear to add independent prediction beyond a comprehensive nicotine measurement. In never-smokers, HEMA showed no link to lung cancer, while different markers (those tracking polycyclic aromatic hydrocarbons) did.

Reconciling the Counterintuitive Finding

It can feel contradictory that a marker of a known carcinogen does not independently predict cancer once you account for nicotine exposure. The framework that resolves this: HEMA and cotinine are both indicators of how much smoke a person has been inhaling. When you measure both, they are reading the same underlying signal (overall smoke dose) through different windows. HEMA is still a valid exposure marker, but in heavy smokers, it does not give you new prognostic information that a thorough nicotine measurement cannot.

Occupational and Environmental Exposure

A study of hospital workers exposed to ethylene oxide used for sterilizing medical equipment found that urinary HEMA rose with workplace exposure levels even at low concentrations. Workers with a functional version of the GSTT1 gene (which codes for the detoxifying enzyme) excreted more HEMA, illustrating that personal genetics influence how much of the detoxified product ends up in urine.

If you live near industrial sites, work in healthcare sterilization, or work in chemical manufacturing, this test can document whether your specific exposure is translating into measurable internal dose. Background levels are detectable in nearly everyone, even non-smokers in the general population.

Childhood Neurodevelopment

A Chinese case-control study of school-age children found that those in the highest quartile of urinary HEMA had nearly twice the odds of dyslexia compared to those in the lowest quartile (odds ratio 1.97, 95% CI 1.20 to 3.23). The mechanism is not understood and this is a single study, so the finding should be treated as preliminary rather than definitive.

Cardiovascular and Respiratory Endpoints

In an NHANES analysis, a panel of urinary volatile organic compound metabolites that included HEMA was associated with increased risk of heart attack. HEMA was part of the overall toxicant burden in that model, not the strongest individual contributor; the strongest individual signals came from other VOC metabolites such as 3HPMA, CYMA, and DHBMA. A separate analysis of chronic respiratory disease mortality also included HEMA in a broader volatile organic compound panel, but the standout risk signals came from acrolein and styrene metabolites, not from HEMA specifically.

Product Switching and Harm Reduction

Several randomized trials and a systematic review have measured HEMA in people switching from cigarettes to heated tobacco or e-cigarette products. HEMA typically drops substantially in these switches, often approaching the levels seen with full smoking abstinence over short trial periods of days to a few months. Long-term cancer outcomes from these switches have not been established.

Why One Reading Is Not Enough

HEMA reflects what your body processed in the past few days, not your average exposure over months or years. A single measurement can be misleading if it captures an unusual day, such as a long flight, a visit to a smoky environment, or a period of intense industrial activity near where you live.

For a more reliable picture, get a baseline reading, then retest at consistent times if you make a meaningful change such as quitting smoking, switching tobacco products, leaving an occupational exposure, or moving away from a high-pollution area. Retest 1 to 2 weeks after the change to confirm a drop, then annually if your environment is stable. If you are tracking the effect of cessation, the substantial reduction within days seen in research is a useful benchmark.

When Results Can Be Misleading

Several factors can shift a single HEMA reading without reflecting your usual exposure:

• Recent secondhand smoke or industrial air: brief exposure in the days before the test can spike your number even if your usual environment is clean.
• Hydration and urine concentration: because HEMA is reported relative to urinary creatinine, dehydration can affect the apparent value. Standardized first-morning samples reduce this variability.
• Genetic differences in detoxification: people with active versions of the GSTT1 enzyme excrete more HEMA for the same exposure, so a higher number can partly reflect efficient detoxification rather than higher exposure.
• Lack of specificity: HEMA is not unique to ethylene oxide. It also reflects acrylonitrile and other reactive two-carbon compounds, so an elevated reading does not by itself pinpoint which chemical you were exposed to.
• Dietary and packaging sources: ethylene oxide residues can be present in some sterilized packaged foods and spices, which may contribute modestly to background readings.

Decision Pathway for an Elevated Result

If your HEMA is higher than expected and you do not smoke, the first step is to audit your exposure: workplace chemicals, proximity to industrial facilities, recent secondhand smoke, and home air quality. Pair the HEMA result with serum or urinary cotinine to confirm whether tobacco smoke is the driver, since cotinine specifically tracks nicotine. If both are elevated, smoke is your primary source. If cotinine is normal but HEMA is high, focus on workplace, environmental, or dietary sources of ethylene oxide and related chemicals.

For occupational concerns, an industrial hygienist or occupational medicine specialist can measure ambient ethylene oxide in your workplace and recommend protective measures. For combined chemical-exposure concerns, complementary urinary mercapturic acid testing for benzene (SPMA), acrolein (HPMA), and 1,3-butadiene (MHBMA) can map your broader toxicant profile. There are no specific medical treatments that lower HEMA other than reducing the exposure itself.